Non-vasogenic cystoid maculopathies.
Gaudric A, Audo I, Vignal C, Couturier A, Boulanger-Scemama É, Tadayoni R, Cohen SY.
Prog Retin Eye Res. 2022 Nov;91:101092. doi: 10.1016/j.preteyeres.2022.101092. Epub 2022 Aug 1.
Behavioral and neurochemical effects of proline.
Wyse AT, Netto CA.
Metab Brain Dis. 2011 Sep;26(3):159-72. doi: 10.1007/s11011-011-9246-x. Epub 2011 Jun 4.
Metabolic studies in older mentally retarded patients: significance of metabolic testing and correlation with the clinical phenotype.
Van Buggenhout GJ, Trijbels JM, Wevers R, Trommelen JC, Hamel BC, Brunner HG, Fryns JP.
Genet Couns. 2001;12(1):1-21.
The chaperone role of the pyridoxal 5'-phosphate and its implications for rare diseases involving B6-dependent enzymes.
Cellini B, Montioli R, Oppici E, Astegno A, Voltattorni CB.
Clin Biochem. 2014 Feb;47(3):158-65. doi: 10.1016/j.clinbiochem.2013.11.021. Epub 2013 Dec 16.
Inborn errors of proline metabolism.
Mitsubuchi H, Nakamura K, Matsumoto S, Endo F.
J Nutr. 2008 Oct;138(10):2016S-2020S. doi: 10.1093/jn/138.10.2016S.
Molecular pathology of gyrate atrophy of the choroid and retina due to ornithine aminotransferase deficiency.
Ramesh V, Gusella JF, Shih VE.
Mol Biol Med. 1991 Feb;8(1):81-93.
Supplementary creatine as a treatment for gyrate atrophy of the choroid and retina.
Sipilä I, Rapola J, Simell O, Vannas A.
N Engl J Med. 1981 Apr 9;304(15):867-70. doi: 10.1056/NEJM198104093041503.
Gyrate atrophy of the choroid and retina. A five-year follow-up of creatine supplementation.
Vannas-Sulonen K, Sipilä I, Vannas A, Simell O, Rapola J.
Ophthalmology. 1985 Dec;92(12):1719-27. doi: 10.1016/s0161-6420(85)34098-8.
Creatine corrects muscle 31P spectrum in gyrate atrophy with hyperornithinaemia.
Heinänen K, Näntö-Salonen K, Komu M, Erkintalo M, Alanen A, Heinonen OJ, Pulkki K, Nikoskelainen E, Sipilä I, Simell O.
Eur J Clin Invest. 1999 Dec;29(12):1060-5. doi: 10.1046/j.1365-2362.1999.00569.x.
Regional expression of disease-related genes in human and monkey retina.
Bernstein SL, Wong P.
Mol Vis. 1998 Nov 5;4:24.
